Completed

Fermented Red Ginseng for Improved Glucose Control in Impaired Fasting Glucose or Type 2 Diabetes

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate if Fermented Red Ginseng can help prevent glucose level spikes in individuals with Impaired Fasting Glucose or Type 2 Diabetes, by observing fasting and post-meal glucose levels before and after the treatment.

What is being tested

Fermented Red Ginseng

+ Placebo

Dietary Supplement
Who is being recruted

Diabetes Mellitus+3

+ Endocrine System Diseases

+ Metabolic Diseases

From 20 to 75 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Placebo-ControlledPhase 2 & 3
Interventional
Study Start: March 2008
See protocol details

Summary

Principal SponsorChonbuk National University Hospital
Last updated: August 29, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2008

Actual date on which the first participant was enrolled.

This study was a 4 weeks, randomized, double-blind, placebo-controlled trial. Forty-two subjects with IFG or type 2 diabetes were randomly allocated to 2 groups to consume placebo or FRG three times per day for 4 weeks. Fasting and postprandial glucose profiles during meal tolerance test were assessed before and after the intervention.

NCT01826409
Principal SponsorChonbuk National University Hospital
Last updated: August 29, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

42 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 20 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Diabetes MellitusEndocrine System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism DisordersDiabetes Mellitus, Type 2

Criteria

1 inclusion criteria required to participate
Age 20-75 years with fasting glucose 100~140 mg/dL at least two of the following
8 exclusion criteria prevent from participating
Abnormal hepatic liver function or renal disease (acute/chronic renal failure or nephrotic syndrome)
Acute or chronic inflammatory disease
Allergic or hypersensitive to any of the ingredients in the test products
Cardiovascular disease (arrhythmia, heart failure, myocardial infarction or patient with pacemaker)
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental

Group II

Placebo

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Clincial Trial Center for Functional Foods

Jeonju, South KoreaOpen Clincial Trial Center for Functional Foods in Google Maps
CompletedOne Study Center